NVIDIA was moving sideways and downward for a while, indicating no clear trend. Now, the price has bounced strongly from around 164, suggest
seen from United Kingdom

seen from Maldives

seen from United States
seen from Georgia
seen from France
seen from Italy
seen from United States
seen from United States
seen from Netherlands
seen from Russia
seen from Germany

seen from Netherlands
seen from Germany
seen from Hong Kong SAR China

seen from Malaysia
seen from United Kingdom

seen from France

seen from Germany
seen from Venezuela

seen from Italy
NVIDIA was moving sideways and downward for a while, indicating no clear trend. Now, the price has bounced strongly from around 164, suggest
Futuristic City on the Horizon by Cata2k30 on DeviantArt
It’ll be a comeback.
Steinberg Valentino Group Scam, Fraud and Extortion
Steinberg Valentino Group is a SCAM. The one man show orchestrated by Ben Steinberg.
The Scammers ask, "Has your smallcap company struggled to find investors? You need a strong investor relations firm and SteinbergValentino Group can drive immediate results. Our IR firm can help immediately drive liquidity, price appreciation and find institutional investors."
The Extortion begins.
First Ben Steinberg makes promises and brilliantly explains the plan and execution.
After a miserable failure, Steinberg Valentino Group (or the one man show) Ben Steinberg begins to spin lies.
Next he demands payment (for nothing).
Finally when the company declines to pay for false promises he begins to post negative publicity and numerous lies.
If you want to avoid Ben Steinberg, President of Steinberg Valentino Group, simply ask for a video call and he will decline. Check the NYC address, 100 Church Street, Suite 8010, Manhattan, New York, 10007 and call the phone numbers listed.
The address is fake and the phones are never answered (only returned). The entire website and social media profile is made up of stock images and real pictures do not exist.
The Possible Healthcare Trend
Sponsored post: After all we’ve been through these past few years, health security appears to become the focus and concern of most of us, and with that in mind also comes a promising potential for sectors that’s in line with health, like these sectors that appears to focus on unmet medical needs. Gather your thoughts in this article to learn the development these past few years of these other sectors and ride along the healthcare trend!
Based on this article and its corresponding youtube video, these other sectors appears to be targeting a major unmet medical need: To treat arthritis, millions of patients seemingly turn to anti-inflammatory painkillers. In fact, about 65% of people in the US with osteoarthritis are prescribed NSAIDs. Unfortunately, NSAIDs could cause adverse events, such as severe GI ulcers and bleeding.
Furthermore, it appears that these other sectors are aiming at a huge market – one that appears to be getting bigger as we all age. According to the US CDC, approximately 23% of adults just in the US, have arthritis. About 24 million are limited with their activities because of it, and roughly 25% of people report severe joint pain. Check disclaimer on profile.
Yes, I get free stocks too. No, I wouldn’t promote this if I didn’t think it was worth it for every single person to do 🚀 🏦 This is the greatest most accessible referral on the block right now. Takes 4 minutes, you get 4 free stocks, AND access to paper trading/Roth Ira, regular investing, options (stay away), cryptocurrency, etc. 🏦 It only lasts until the end of tomorrow so make sure to deposit the $100 as soon as you make an account! (You get 2 free stocks before the deposit is made, usually valued less and then 2 more after! Valued $8-$1200) Follow @funancialism for investing content —- 🍎 LINK IN BIO to FREE investing videos: how I saved $100K in college, how to make a Roth IRA, when to sell a stock (I had 12K profit) . Disclaimer: not a advice, just a random persons internet opinion . . #funancialism #savingmoney #extremecouponing #financialindependence #neverpayretail #couponingcommunity #neverpayfullprice #personalfinance #bcba #stockstowatch #financialgoals #daveramsey #debtfree #debtfreecommunity #debtfreejourney #babystep3 #stockmarket #budgeting #investments #homedecoration #investing101 #budgetplanner #resellercommunity #nurselife #softwaretesting #appliedbehavioranalysis #financialindependenceretireearly #budget #teachersofinstagram (at Los Angeles, California) https://www.instagram.com/p/CJcXKiUHA3t/?igshid=1i1gtmipm5brk
Small Cap Biotech Stocks See Boost From Large Cap M&A
Cancer has been a problem plaguing society for at least half a century. However, the fight to defeat cancer has picked up steam in the 21st century. More and more companies are making it their missions to develop treatments for many forms of cancer. From penny stocks to large-cap stocks, biotechnology companies are breaking new ground.
Source link : Small Cap Biotech Stocks See Boost From Large Cap M&A
GT Bio pharma Inc. (GTBP) is a small-cap biotech company that creates immune-oncology products. They utilize a technology platform that combines antibody-drug linkers to single-chain, bi-, tri-, and tetra-specific scFv constructs to produce treatments. One example is for carcinoma, called OXS-1615, which is a tetraspecific treatment.
Recently, GT Biopharma has been making advances for their GTB-1550 treatment. This treatment aims to treat Non-Hodgkin’s Lymphoma and Leukemia. They recently announced the results of GTB-1550’s phase I and II clinical trials. The results showed positive results including one patient becoming cancer-free post treatment.